Multidrug efflux pumps contribute to multiple antibiotic resistance in Pseudomonas aeruginosa. Pump expression usually has been quantified by Western blotting. Quantitative real-time polymerase chain reaction has been developed to measure mRNA expression for genes of interest. Whether this method correlates with pump protein quantities is unclear. We devised a real-time PCR for mRNA expression of MexAB-OprM and MexXY-OprM multidrug efflux pumps. In laboratory strains differing in MexB and MexY expression and in several clinical isolates, protein and mRNA expression correlated well. Quantitative real-time PCR should be a useful alternative in quantitating expression of multidrug efflux pumps by P. aeruginosa isolates in clinical laboratories.
Introduction
Pseudomonas aeruginosa is a clinically important pathogen showing greater intrinsic resistance than most other Gram-negative bacteria to a number of antimicrobial agents. This intrinsic resistance problem is compounded by increasingly frequent development of acquired resistance to agents that ordinarily show potent activity against this organism [1, 2] . Thus P. aeruginosa, a major opportunistic pathogen, is becoming increasingly difficult to eradicate. Several mechanisms are known by which this microorganism escapes the toxic effects of antimicrobial agents. These include production of inactivating enzymes, mutations of target enzymes, and multidrug efflux pumps [3] [4] [5] [6] . The pumps, especially the resistancenodulation-division (RND) family, have received particular recent attention because they can extrude multiple structurally unrelated compounds, and thus are involved in multidrug resistance [3, 4, 7] . To date, at least seven RND family drug efflux pumps are known to exist in P. aeruginosa cells. Among them, MexAB-OprM, which is expressed constitutively in wild-type strains, contributes to the intrinsic resistance of P. aeruginosa to most b-lactams and many other structurally unrelated antimicrobial agents [2, 8, 9] . MexXY-OprM also is involved in the intrinsic resistance of P. aeruginosa to several agents, such as fourth-generation cephems, tetracyclines, erythromycin, and gentamicin [10, 11] . Since expression of MexCD-OprJ and MexEF-OprN is strictly suppressed by the respective regulator genes in wild-type P. aeruginosa cells, neither of these efflux pumps are involved in intrinsic antibiotic resistance; they contribute only to acquired resistance [12, 13] .
An important part of investigating resistance mechanisms involving these efflux pumps in P. aeruginosa is determination of pump expression levels in laboratory strains or in clinical isolates. Conventionally, this has been done by Western blotting using monoclonal or polyclonal antibodies [1, 2, 9, 14] . However, this method is complex and time-consuming, and the antibodies are not commercially available. A recently, developed new technique, quantitative real-time polymerase chain reaction (PCR), can measure mRNA expression for genes of interest. This method has proven highly accurate and reproducible in quantitating gene expression [15] , and can quantify a given mRNA within a very large range of amounts [16] . However, the practicality of using this method to quantify gene expression of P. aeruginosa efflux pumps, as well as correlations of mRNA amounts with pump protein amounts, are uncertain. We set out to devise a real-time PCR as a sensitive, easily performed quantitative method for determining expression of two efflux pumps, MexAB-OprM and MexXY-OprM, that contribute to both intrinsic and acquired resistance. We considered this procedure as a possible alternative to quantification of pump proteins by Western blotting.
Materials and methods

Bacterial strains, media and growth conditions
The strains used in this study are shown in Table 1 [1, 17, 18] . P. aeruginosa clinical isolates were randomly selected from our collection at Tottori university hospital and Kyoto pharmaceutical university. Bacterial cells were grown in Luria-Bertani broth (LB) (Wako Pure Chemical Industries, Osaka, Japan). All bacterial cultures in LB were incubated at 37°C with shaking (140 rpm) for 12.5 h.
Isolation of total membranes, SDS-PAGE, and immunoblot analysis
Cells grown in LB were harvested by centrifugation and total membranes were prepared as described previously [17] . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrophoretic transfer was performed as described previously [17] . The fractionated proteins were subjected to immunoblot analysis using anti-MexB rabbit-peptid antisera [17] or anti-MexY rabbit polyclonal antibody [32] as the primary antibodies and horseradish peroxidase-linked appropriate secondary antibodies (Pharmacia). The binding antibodies were detected using ECL plus Western blotting detection reagents (Amersham Pharmacia Biotech) according to the manufactureÕs instructions.
Cloning in plasmids and quantification of number of copies of the plasmids
Plasmids containing amplified sequences of PAO1 strain were constructed with the pGEM-T Easy Vector Systems (Promega, Tokyo, Japan) according to the manufactureÕs instructions. Briefly, the fragments of mexB, mexY and rpsL genes, 244, 246 and 241 bp, respectively, were amplified by conventional PCR with the primers listed in Table 2 . The fragments were cloned into pGEM-T Easy Vector. DH5a Escherichia coli were transformed with these constructions, and after expansion in culture, the plasmids were purified by the Minipreps DNA Purification System (Promega). Gene quantification was performed with the BECKMAN DU-64 Spectrophotometer (Beckman Instruments, CA, USA) at a wavelength of 260 nm, and the number of copies was calculated. These plasmids were used as external standards. For each batch, serial plasmid dilutions were amplified; this allowed the construction of a standard curve and the quantification of mRNA in samples.
RNA extraction and cDNA synthesis
Total RNA was extracted from the 250 ll of cultured medium using QIAGEN RNeasy Mini Kit (Qiagen, Tokyo, Japan), and residual DNA was removed by adding DNase I using QIAGEN RNase-Free DNase Set (Qiagen) according to the manufactureÕs instructions. RNA was finally dissolved in 50 ll of RNase-free water. For cDNA synthesis, each 20 ll reaction contained 1 lg of total RNA, 10 lg of random hexamer, 1 · first strand buffer (50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 ; Invitrogen, Tokyo, Japan), 0.5 mM dNTP, 10 U of RNase inhibitor (Invitrogen), and 200 U of Super Script II (Invitrogen). cDNA synthesis was performed in a TaKaRa PCR Thermal Cycler (Takara, Kyoto, Japan) according to the following procedure: after an annealing step for 10 min at 70°C, reverse transcription was carried out for 50 min at 42°C, followed by reverse transcriptase inactivation for 10 min at 95°C.
Quantitative real-time PCR
The LightCycler (Roche, Tokyo, Japan) was used for all quantitative PCRs. All PCR amplification reactions were performed in a 10 ll volume containing a 3 mM concentration of MgCl 2 , a 1 lM concentration of forward primers, a 1 lM concentration of reverse primers, 1 · FastStart DNA Master SYBR Green I (Roche), and 1 ll of diluted cDNA (1:10). The cycling parameters used were as follows: one denaturation cycle for 600 s at 95°C and 45 amplification cycles (temperature transition rate of 20°C s À1 ) for 15 s at 95°C, annealing for 5 s at 55°C, extension for 10 s at 72°C. Fluorescence readings were taken after each cycle following the extension step. This was followed by melting curve analysis of 65-99°C (temperature transition rate of 0.1°C s À1 ) with continuous fluorescence readings. For each gene being measured, a sequence-specific standard curve was generated using 10-fold serial dilutions of plasmid DNA containing the sequence of interest and using the appropriate primers. The LightCycler software generated a standard curve from the standards and determined the gene copy number in each test sample. The ratios of gene expression between the target genes (mexB, mexY) and internal standard (rpsL) were expressed relative to those of PAO1 or KG4545, which is set at 1.00.
Results
Design of a real-time PCR assay for quantitative analysis of multidrug efflux pump
MexAB-OprM is considered the most important multidrug efflux pump in P. aeruginosa, being involved in broad resistance to cephems, penicillins, monobactams and carbapenems. We therefore first developed a quantitative real-time PCR assay targeted to mexB gene expression. Primer sequences were chosen from a region of the mexB gene that was preserved among the bacterial strains used in this study, according to DNA sequencing. In addition, an extensive search of several databases, including the EMBL and GenBank databases, indicated that no primer shared significant homology with other known nucleotides sequenced. To determine the copy number of mexB gene in sample, a standard curve was established with a control plasmid, pGEM-T/MexB, that contained the target mexB partial sequences. The control plasmid was diluted 10-fold with water in a serial manners, from 48 to 4.8 · 10 7 copies/ll, and each sample was submitted to the mexB real-time PCR ( Fig. 1(a) ). The threshold cycle number, which corresponds to the PCR cycle number at which the fluorescence signal exceeded the detection threshold, was plotted against each of logarithmically increasing standard DNA concentrations. As shown in Fig. 1(b) , a linear relationship was obtained over on at least 7-log range of cDNA concentrations.
As MexXY-OprM is the other efflux pump system that contributes to intrinsic and acquired resistance to fourth-generation cephems and aminoglycoside derivative antibiotics, we similarly established a quantitative real-time PCR assay targeted to mexY gene expression. The range of quantification was from 88 to 8.8 · 10 7 copies/ll of pGEM-T/MexY construct (data not shown).
To compensate for varying numbers of cells in samples and efficiency of the reverse transcription reaction, we developed a quantitative real-time PCR reaction for rpsL, a constitutively expressed 30S rRNA gene, for use as an internal standard [19] . The sequences of primers were based on previous the report which used them for conventional RT-PCR [20] . Quantitation proved to be linear over a wide logarithmical range, from 57 to 5.7 · 10 7 copies/l of pGEM-T/RpsL construct (data not shown).
Correlation between protein and mRNA expression of multidrug efflux pump in laboratory strains
We next used the real-time PCR assay to examine the correlation between protein and mRNA expression of MexB. For this purpose we used four laboratory strains, PAO1, OCR1, KG2212, and KG2239, that had been developed to express MexB to different degrees (Table  1) . First we performed Western analysis to quantify protein expression of MexB in these bacterial strains ( Fig.  2(a) ). Densitometry of the MexB bands respectively showed protein expression in OCR1 and in KG2212 to be 2.9 and 1.3 times greater than in the control strain (PAO1), while no MexB band could be detected in KG2239 ( Fig. 2(a) ). Up-and down-regulation of MexB was investigated further by real-time PCR after culture under the same conditions. Expression of mexB mRNA in OCR1 and KG2212 respectively was 4 and 2.4 times greater than in PAO1, while only traces of mexB mRNA were found in KG2239 (Fig. 2(b) ). Expression patterns of protein and mRNA thus were highly similar to one another in these laboratory strains. Next we examined the correlation between protein and mRNA expression of MexY in three laboratory strains, PAO1, KG5005, and KG4545 (Table 1) . Western analysis detected bands at 113 kDa representing the MexY protein in KG5005 and KG4545, while no band was seen in PAO1 (Fig. 2(c) ). Quantification of the MexY bands showed high degrees of protein expression in KG5005 and KG4545, with expression of KG5005 being twice that of KG4545 (Fig. 2(c) ). When expression of mexY was examined further by real-time PCR after culture under the same conditions, mRNA expression of mexY in KG5005 was 1.2 times that in KG4545, while expression in PAO1 was only 26% of that in KG4545 (Fig. 2(d) ). These results were consistent with those of Western blotting.
Correlation between protein and mRNA expression of multidrug efflux pump in clinical isolates
Since laboratory strains chosen to vary in pump expression showed good correlations between protein and mRNA expression of both MexB and MexY, we next examined the relationship between protein and mRNA expression of MexB in randomly selected clinical isolates (T001 to T009; Table 1 ). As shown in Fig.  3(a) , isolates T001, T002, T003, and T005 showed 1.6-2.3 times greater expression of MexB protein than did PAO1. On the other hand, T004 and T006 to T009, showed 50-100% lower expression than that in PAO1. Corresponding to this protein expression, mRNA expression measured by real-time PCR was higher than in PAO1 in T001, T002, and T003, but lower in T004 and T006 to T009 (Fig. 3(a) ). The only exception was T005, which expressed 2.3 times as much protein as PAO1, but only slightly more mRNA.
Next, the same clinical isolates were examined concerning the relationship between protein and mRNA expression of MexY. By Western blotting, in T002 to T006, expression of MexY protein was equal to or greater than that in KG4545, while T001, T007, T008, and T009, like PAO1, did not express detectable MexY protein. In real-time PCR, T002 to T006 expressed more mexY mRNA than KG4545, while T001, T007, T008, and T009 as well as PAO1 expressed only very small amounts of mexY mRNA (Fig. 3(b) ). Although amounts of protein were relatively small considering those of mRNA in T006, expression patterns of both mRNA and protein levels were quite similar in all other clinical strains. These data showed a general trend of increased protein resulting from increased mRNA.
Discussion
In this study we developed a quantitative real-time PCR assay to assess two multidrug efflux pumps in P. aeruginosa, MexB and MexY, and examined the relationship between mRNA expression measured by this real-time PCR and protein expression measured by Western blotting. Results obtained with our method, involving RNA isolation, cDNA synthesis, and quantitative real-time PCR, were highly reproducible and permitted precise quantification of minute or substantial amounts of mexB or mexY mRNA transcripts. Real-time PCR assay allowing quantification of efflux pump gene transcripts relative to those of the 30S rRNA gene, rpsL, showed good correlation with MexB and MexY protein expression in laboratory and clinical strains. This realtime PCR would appear to be a useful alternative method for assessing the multidrug efflux pumps MexB and MexY in P. aeruginosa.
Of the several techniques developed to estimate protein or mRNA expression, Western blotting is considered the ''gold standard'' for quantifying expression of multidrug efflux pumps in P. aeruginosa. Since this method is time-consuming and requires specific antibodies not commercially available, it has not been widely implemented in clinical laboratories. Real-time PCR has several practical advantages over Western analysis. First, real-time PCR has great sensitivity and a wide effective range. Even though the efflux pump proteins were not detectable in several of our strains, small amounts of corresponding mRNA could be detected and measured in all strains. Secondly, real-time PCR has high throughput and is less labor-intensive than Western analysis; it is a closed-tube system that does not require post-PCR handling. In our experience, total time for specimen processing and analysis is 3-4 h. Third, our application of real-time PCR has broad accessibility, being easy to perform in any laboratory with real-time PCR equipment as long as specific primers have been prepared. Therefore, real-time PCR is an attractive method for estimating gene expression for efflux pumps in bacteria.
As protein expression dose not always exactly reflect mRNA transcription, in case using mRNA expression profiles to presume the protein expression levels, we first needs to confirm the closeness of quantitative correlation of individual proteins with the corresponding mRNA. For example, while several reports have described good correlations between amounts of specific mRNA and corresponding protein expression [21, 22] , exhaustive studies of bacteria or fungi have reported no significant general correlation between protein and mRNA abundance [22] [23] [24] . As for multidrug efflux pumps in P. aeruginosa, the few previous studies estimating mRNA expression of these genes by conventional RT-PCR [25] , or very recently by real-time PCR [19, 26] . However, these works lacked the validation of a correlation between amounts of protein and mRNA expression. We therefore specifically examined this correlation, finding it to be significant for MexB and MexY in P. aeruginosa. Our results suggest that quantitative analysis of mRNA by real-time PCR might be a useful indicator of corresponding MexB and MexY protein quantities in lieu of Western blotting.
Although mRNA expression correlated well with protein expression levels in laboratory strains, some clinical isolates showed subtle discrepancies between protein and mRNA expression. Many molecular mechanisms causing these discrepancies have been reported to date. Such mechanisms include post-transcriptional control of the protein translation rate [27] , the half-lives of specific proteins or mRNAs [28] , and the molecular association of the protein products of expressed genes [29] . Clinical isolates have diverse genetic backgrounds, unlike laboratory strains that are isogenic with a reference strain such as PAO1. Heterogeneity in clinical isolates affects above regulatory mechanisms of transcription, translation, and proteolysis, leading to the discrepancies. In our study, all discrepancies shown in T005 or T006 appear likely to involve overall genetic heterogeneity of the strains, and therefore may be inevitable to some degree in clinical isolates.
In conclusion, real-time PCR based on the capillary format of the LightCycler instrument proved to be a simple, rapid, sensitive, and specific way to quantify multidrug efflux pumps in P. aeruginosa. Multidrug resistance of P. aeruginosa involves on interplay among multiple resistance mechanisms: b-lactamase, the outer membrane barrier, and multidrug efflux pumps [30, 31] ; optimal treatment will require a practical method for assessing the latter. Clinical laboratories should be able to estimate expression of these pumps by this method, permitting optimal choices involving antimicrobial agents, as well as antibiotics available for use with multidrug efflux pump inhibitors.
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